Recorded fact · drug.label_indication
drug.label_indication for enasidenib-mesylate|acute-myeloid-leukemia
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 8cc3cc09 resolves to.
The record
| Fact id | 8cc3cc097a674e86a15ac953 |
|---|---|
| Entity | drug: enasidenib-mesylate|acute-myeloid-leukemia |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250116 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test ( 1.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: ae0154e9c42640ebd9a39582e08ddac5a2f23b14a1c60d624ee74bf6263aefc3.
The value
{
"ingredient": "Enasidenib Mesylate",
"conditionId": "acute-myeloid-leukemia",
"conditionName": "Acute Myeloid Leukemia",
"matchedAlias": "acute myeloid leukemia",
"context": "indication",
"brand": "Idhifa",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6",
"labelEffectiveTime": "20250116",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 39e178ead1a87d172c779014444989df50a615048055aa3e01490eb4d41ec0dd.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.